| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 3.61e-08 | 15 | 47 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.48e-05 | 562 | 47 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | structural constituent of tooth enamel | 8.09e-05 | 6 | 47 | 2 | GO:0030345 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.39e-04 | 112 | 47 | 4 | GO:0090079 | |
| GeneOntologyMolecularFunction | hydroxyapatite binding | 1.50e-04 | 8 | 47 | 2 | GO:0046848 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.85e-04 | 14 | 47 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.09e-04 | 303 | 47 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 1.33e-03 | 23 | 47 | 2 | GO:0030021 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.60e-03 | 739 | 47 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.70e-03 | 26 | 47 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.11e-03 | 231 | 47 | 4 | GO:0005085 | |
| GeneOntologyBiologicalProcess | female meiosis II | 3.54e-10 | 6 | 47 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 3.54e-10 | 6 | 47 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 3.54e-10 | 6 | 47 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 3.41e-07 | 26 | 47 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 4.18e-07 | 307 | 47 | 8 | GO:0090068 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 5.39e-07 | 29 | 47 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 7.12e-07 | 31 | 47 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 1.48e-06 | 37 | 47 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 3.29e-06 | 45 | 47 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 3.44e-06 | 407 | 47 | 8 | GO:0045787 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 3.93e-06 | 47 | 47 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 5.91e-06 | 52 | 47 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 6.28e-06 | 115 | 47 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 2.55e-05 | 75 | 47 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 2.83e-05 | 77 | 47 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 3.63e-05 | 82 | 47 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 4.59e-05 | 87 | 47 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 4.80e-05 | 88 | 47 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 5.47e-05 | 91 | 47 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | oocyte development | 7.60e-05 | 99 | 47 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 8.22e-05 | 101 | 47 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 8.87e-05 | 103 | 47 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 9.32e-05 | 1256 | 47 | 11 | GO:0051726 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 1.05e-04 | 845 | 47 | 9 | GO:0010564 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 1.50e-04 | 118 | 47 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 2.11e-04 | 240 | 47 | 5 | GO:0140013 | |
| GeneOntologyBiologicalProcess | translational initiation | 2.31e-04 | 132 | 47 | 4 | GO:0006413 | |
| GeneOntologyBiologicalProcess | cell cycle process | 3.12e-04 | 1441 | 47 | 11 | GO:0022402 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 3.50e-04 | 268 | 47 | 5 | GO:1903046 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 3.66e-04 | 999 | 47 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 3.85e-04 | 151 | 47 | 4 | GO:0045727 | |
| GeneOntologyBiologicalProcess | oogenesis | 4.36e-04 | 156 | 47 | 4 | GO:0048477 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.83e-04 | 443 | 47 | 6 | GO:1903311 | |
| GeneOntologyBiologicalProcess | negative regulation of circadian rhythm | 5.98e-04 | 16 | 47 | 2 | GO:0042754 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 6.30e-04 | 172 | 47 | 4 | GO:0051783 | |
| GeneOntologyBiologicalProcess | chromatin organization | 8.57e-04 | 896 | 47 | 8 | GO:0006325 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 9.96e-04 | 917 | 47 | 8 | GO:0016071 | |
| GeneOntologyBiologicalProcess | nuclear division | 1.03e-03 | 512 | 47 | 6 | GO:0000280 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 1.17e-03 | 350 | 47 | 5 | GO:0051321 | |
| GeneOntologyBiologicalProcess | enamel mineralization | 1.47e-03 | 25 | 47 | 2 | GO:0070166 | |
| GeneOntologyBiologicalProcess | female gamete generation | 1.65e-03 | 223 | 47 | 4 | GO:0007292 | |
| GeneOntologyBiologicalProcess | organelle fission | 1.80e-03 | 571 | 47 | 6 | GO:0048285 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | 1.84e-03 | 574 | 47 | 6 | GO:0010638 | |
| GeneOntologyCellularComponent | nuclear body | 1.85e-04 | 903 | 48 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | transcription regulator complex | 3.95e-04 | 596 | 48 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 9.73e-04 | 1377 | 48 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 9.83e-04 | 85 | 48 | 3 | GO:0000118 | |
| HumanPheno | Y-linked inheritance | 4.07e-05 | 18 | 20 | 3 | HP:0001450 | |
| HumanPheno | Cryptorchidism | ZNF462 DAZ4 BRD4 FBXO11 DAZ1 SIN3A DAZ3 DAZ2 SRCAP KMT2E SOS2 | 4.50e-05 | 780 | 20 | 11 | HP:0000028 |
| HumanPheno | Oligozoospermia | 6.85e-05 | 59 | 20 | 4 | HP:0000798 | |
| MousePheno | short Tomes' process | 9.24e-06 | 2 | 43 | 2 | MP:0030513 | |
| MousePheno | absent ovarian follicles | 1.75e-05 | 51 | 43 | 4 | MP:0002777 | |
| MousePheno | abnormal Tomes' process morphology | 2.77e-05 | 3 | 43 | 2 | MP:0030512 | |
| MousePheno | large mandible | 5.52e-05 | 4 | 43 | 2 | MP:0030050 | |
| MousePheno | enamel pits | 9.19e-05 | 5 | 43 | 2 | MP:0030460 | |
| MousePheno | short upper incisors | 1.38e-04 | 6 | 43 | 2 | MP:0030090 | |
| MousePheno | small upper incisors | 1.92e-04 | 7 | 43 | 2 | MP:0030081 | |
| MousePheno | short lower incisors | 1.92e-04 | 7 | 43 | 2 | MP:0030089 | |
| MousePheno | abnormal enamel rod pattern | 2.56e-04 | 8 | 43 | 2 | MP:0002649 | |
| MousePheno | abnormal tooth wear | 4.09e-04 | 10 | 43 | 2 | MP:0030458 | |
| MousePheno | decreased post-tetanic potentiation | 4.99e-04 | 11 | 43 | 2 | MP:0002922 | |
| MousePheno | small lower incisors | 4.99e-04 | 11 | 43 | 2 | MP:0030080 | |
| MousePheno | brittle teeth | 5.98e-04 | 12 | 43 | 2 | MP:0000126 | |
| MousePheno | reduced enamel thickness | 5.98e-04 | 12 | 43 | 2 | MP:0002577 | |
| MousePheno | increased lung tissue damping | 7.06e-04 | 13 | 43 | 2 | MP:0011047 | |
| MousePheno | abnormal enamel mineralization | 7.06e-04 | 13 | 43 | 2 | MP:0030450 | |
| MousePheno | arrest of spermatogenesis | 7.94e-04 | 239 | 43 | 5 | MP:0001155 | |
| MousePheno | short incisors | 8.22e-04 | 14 | 43 | 2 | MP:0004830 | |
| MousePheno | abnormal seminiferous tubule morphology | 9.69e-04 | 377 | 43 | 6 | MP:0002216 | |
| MousePheno | abnormal lung tissue damping | 1.08e-03 | 16 | 43 | 2 | MP:0011046 | |
| MousePheno | abnormal molar cusp morphology | 1.08e-03 | 16 | 43 | 2 | MP:0030457 | |
| MousePheno | abnormal incisor color | 1.08e-03 | 16 | 43 | 2 | MP:0010096 | |
| Domain | RRM | 6.22e-08 | 217 | 47 | 8 | SM00360 | |
| Domain | RRM_dom | 8.80e-08 | 227 | 47 | 8 | IPR000504 | |
| Domain | - | 1.53e-07 | 244 | 47 | 8 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.35e-07 | 258 | 47 | 8 | IPR012677 | |
| Domain | RRM_1 | 8.28e-07 | 208 | 47 | 7 | PF00076 | |
| Domain | RRM | 1.62e-06 | 230 | 47 | 7 | PS50102 | |
| Domain | Amelogenin | 6.20e-06 | 2 | 47 | 2 | IPR004116 | |
| Domain | Amelogenin | 6.20e-06 | 2 | 47 | 2 | SM00818 | |
| Domain | Amelogenin | 6.20e-06 | 2 | 47 | 2 | PF02948 | |
| Domain | GDS_CDC24_CS | 1.28e-04 | 39 | 47 | 3 | IPR001331 | |
| Domain | DH_1 | 5.34e-04 | 63 | 47 | 3 | PS00741 | |
| Domain | PH | 6.48e-04 | 278 | 47 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 6.59e-04 | 279 | 47 | 5 | PS50003 | |
| Domain | PH_dom-like | 6.61e-04 | 426 | 47 | 6 | IPR011993 | |
| Domain | RhoGEF | 6.67e-04 | 68 | 47 | 3 | SM00325 | |
| Domain | PH_domain | 6.70e-04 | 280 | 47 | 5 | IPR001849 | |
| Domain | DH_2 | 7.26e-04 | 70 | 47 | 3 | PS50010 | |
| Domain | RhoGEF | 7.26e-04 | 70 | 47 | 3 | PF00621 | |
| Domain | DH-domain | 7.57e-04 | 71 | 47 | 3 | IPR000219 | |
| Domain | - | 7.57e-04 | 71 | 47 | 3 | 1.20.900.10 | |
| Domain | - | 2.17e-03 | 218 | 47 | 4 | 1.10.10.10 | |
| Domain | - | 2.92e-03 | 391 | 47 | 5 | 2.30.29.30 | |
| Domain | WHTH_DNA-bd_dom | 3.17e-03 | 242 | 47 | 4 | IPR011991 | |
| Domain | F-box | 1.24e-02 | 67 | 47 | 2 | PF00646 | |
| Pathway | WP_OVARIAN_INFERTILITY | 2.46e-06 | 35 | 39 | 4 | MM15948 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.61e-05 | 301 | 39 | 7 | MM15983 | |
| Pathway | WP_MRNA_PROCESSING | 2.65e-05 | 451 | 39 | 8 | MM15946 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 3.94e-04 | 52 | 39 | 3 | MM14743 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 5.72e-04 | 59 | 39 | 3 | M11215 | |
| Pathway | WP_MALE_INFERTILITY | 6.68e-04 | 145 | 39 | 4 | M39856 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 7.65e-04 | 15 | 39 | 2 | M47593 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 8.73e-04 | 16 | 39 | 2 | M39882 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 9.43e-04 | 70 | 39 | 3 | MM14824 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.20e-03 | 76 | 39 | 3 | M19832 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.20e-03 | 439 | 39 | 6 | MM15595 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.24e-03 | 77 | 39 | 3 | MM15044 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.34e-03 | 175 | 39 | 4 | MM15599 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.36e-03 | 450 | 39 | 6 | M27078 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.39e-03 | 80 | 39 | 3 | M800 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.62e-03 | 184 | 39 | 4 | M41809 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.65e-03 | 85 | 39 | 3 | MM14746 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.75e-03 | 188 | 39 | 4 | MM15828 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 3.48e-12 | 4 | 49 | 4 | 15066457 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 7670487 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 3.48e-12 | 4 | 49 | 4 | 26232607 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 11694340 | ||
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 9321470 | ||
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 3.48e-12 | 4 | 49 | 4 | 11095434 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 3.48e-12 | 4 | 49 | 4 | 11688365 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 3.48e-12 | 4 | 49 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 3.48e-12 | 4 | 49 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 3.48e-12 | 4 | 49 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 3.48e-12 | 4 | 49 | 4 | 12801575 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 23298641 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 23579190 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 1.74e-11 | 5 | 49 | 4 | 22223682 | |
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 1.74e-11 | 5 | 49 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 1.74e-11 | 5 | 49 | 4 | 9288969 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 20008336 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 1.74e-11 | 5 | 49 | 4 | 8679003 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 1.74e-11 | 5 | 49 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 1.74e-11 | 5 | 49 | 4 | 8968756 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 1.74e-11 | 5 | 49 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 1.74e-11 | 5 | 49 | 4 | 26411291 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 1.74e-11 | 5 | 49 | 4 | 10903443 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 1.74e-11 | 5 | 49 | 4 | 23223451 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 34985827 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 11804965 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 9143498 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 1.74e-11 | 5 | 49 | 4 | 14648873 | |
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 1.74e-11 | 5 | 49 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 1.74e-11 | 5 | 49 | 4 | 8845845 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 8896558 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 1.74e-11 | 5 | 49 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 1.74e-11 | 5 | 49 | 4 | 19783541 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 22293198 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 17761180 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 19468308 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 9700189 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 1.74e-11 | 5 | 49 | 4 | 12200456 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 11514340 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 21270429 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 11089564 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 8661148 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 32170089 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 5.20e-11 | 6 | 49 | 4 | 15066460 | |
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 16278232 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 20157580 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 5.20e-11 | 6 | 49 | 4 | 18452650 | |
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 17219433 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 5.20e-11 | 6 | 49 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 5.20e-11 | 6 | 49 | 4 | 16001084 | |
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 32962040 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 5.20e-11 | 6 | 49 | 4 | 1869307 | |
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 11390979 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 24086306 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 27632217 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 5.20e-11 | 6 | 49 | 4 | 14611632 | |
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 5.20e-11 | 6 | 49 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 5.20e-11 | 6 | 49 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 5.20e-11 | 6 | 49 | 4 | 23417416 | |
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 11410654 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 15081113 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 22699423 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 11604102 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 10857750 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 1.21e-10 | 7 | 49 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 1.21e-10 | 7 | 49 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 1.21e-10 | 7 | 49 | 4 | 16946704 | |
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 10951504 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 2.42e-10 | 8 | 49 | 4 | 23204224 | |
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 29883445 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 2.42e-10 | 8 | 49 | 4 | 32339196 | |
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 10823932 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 22621333 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 32686646 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 11869379 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 4.36e-10 | 9 | 49 | 4 | 26378784 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 4.36e-10 | 9 | 49 | 4 | 16310179 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 4.36e-10 | 9 | 49 | 4 | 19695304 | |
| Pubmed | 4.36e-10 | 9 | 49 | 4 | 28235998 | ||
| Pubmed | 4.36e-10 | 9 | 49 | 4 | 20159962 | ||
| Pubmed | 5.21e-10 | 29 | 49 | 5 | 34175335 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 10601091 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 7.25e-10 | 10 | 49 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 7.25e-10 | 10 | 49 | 4 | 38433229 | |
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 9922113 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 23810942 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 12837688 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 1.14e-09 | 11 | 49 | 4 | 34401671 | |
| Pubmed | Retinoic acid activates two pathways required for meiosis in mice. | 1.71e-09 | 12 | 49 | 4 | 25102060 | |
| Pubmed | 1.71e-09 | 12 | 49 | 4 | 32054698 | ||
| Interaction | SIN3B interactions | 2.08e-05 | 147 | 46 | 5 | int:SIN3B | |
| Interaction | CEP55 interactions | 2.42e-05 | 256 | 46 | 6 | int:CEP55 | |
| Interaction | SNX18 interactions | 3.48e-05 | 81 | 46 | 4 | int:SNX18 | |
| Interaction | CTBP1 interactions | 3.48e-05 | 406 | 46 | 7 | int:CTBP1 | |
| Interaction | HCFC1 interactions | 5.15e-05 | 293 | 46 | 6 | int:HCFC1 | |
| Interaction | CREBBP interactions | 5.60e-05 | 599 | 46 | 8 | int:CREBBP | |
| Interaction | NAA40 interactions | SFPQ REPS1 NACC1 PRRC2C ATF7IP ACIN1 PTPN23 PPP1R9B SIN3A SRCAP | 5.72e-05 | 978 | 46 | 10 | int:NAA40 |
| Cytoband | Yq11.223 | 3.12e-06 | 93 | 49 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 3.44e-04 | 311 | 49 | 4 | chrYq11 | |
| GeneFamily | RNA binding motif containing | 1.45e-07 | 213 | 35 | 7 | 725 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.80e-04 | 66 | 35 | 3 | 722 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.06e-03 | 25 | 35 | 2 | 775 | |
| GeneFamily | Cyclins|F-boxes other | 2.58e-03 | 39 | 35 | 2 | 560 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.30e-03 | 206 | 35 | 3 | 682 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 5.28e-09 | 12 | 49 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 5.28e-09 | 12 | 49 | 4 | MM781 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | REPS1 DAZ4 ATF7IP MED9 FBXO11 DAZ1 ELK1 DAZ3 DAZ2 SRCAP ARHGEF11 SHISAL1 | 7.96e-08 | 909 | 49 | 12 | M41018 |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 9.30e-08 | 23 | 49 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 3.27e-07 | 31 | 49 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 4.24e-07 | 33 | 49 | 4 | MM701 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 8.50e-07 | 93 | 49 | 5 | MM1185 | |
| Coexpression | MADAN_DPPA4_TARGETS | 2.04e-05 | 86 | 49 | 4 | MM1312 | |
| Coexpression | MCCABE_BOUND_BY_HOXC6 | 2.26e-05 | 461 | 49 | 7 | M6376 | |
| Coexpression | GRADE_COLON_VS_RECTAL_CANCER_DN | 1.59e-04 | 56 | 49 | 3 | M9435 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.72e-04 | 856 | 49 | 8 | M4500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | 8.52e-05 | 482 | 47 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.55e-05 | 105 | 47 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.17e-04 | 350 | 47 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 1.44e-04 | 46 | 47 | 3 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.63e-04 | 124 | 47 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 2.20e-04 | 53 | 47 | 3 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | 2.54e-04 | 979 | 47 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.61e-04 | 406 | 47 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.86e-04 | 413 | 47 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 3.08e-04 | 790 | 47 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 3.38e-04 | 801 | 47 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 3.52e-04 | 806 | 47 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 4.22e-04 | 66 | 47 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 4.75e-04 | 843 | 47 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 5.45e-04 | 72 | 47 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.69e-06 | 200 | 49 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | boron trichloride | 2.83e-10 | 6 | 49 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 3.38e-08 | 16 | 49 | 4 | CID000162558 | |
| Drug | 2-chlorodideoxyadenosine | 3.39e-08 | 43 | 49 | 5 | CID000072194 | |
| Drug | dazmegrel | 7.16e-08 | 19 | 49 | 4 | CID000053555 | |
| Drug | YM 026 | 7.16e-08 | 19 | 49 | 4 | CID000004443 | |
| Drug | azafagomine | 1.44e-07 | 57 | 49 | 5 | CID011957435 | |
| Drug | AZFd | 1.63e-07 | 23 | 49 | 4 | CID000196489 | |
| Drug | dansylaziridine | 1.63e-07 | 23 | 49 | 4 | CID000104008 | |
| Drug | d-gluconhydroximo-1,5-lactam | 5.71e-07 | 31 | 49 | 4 | CID000003479 | |
| Drug | p11-13 | 5.77e-07 | 75 | 49 | 5 | CID000015759 | |
| Drug | Vistar | 1.06e-06 | 36 | 49 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 1.06e-06 | 36 | 49 | 4 | CID000001649 | |
| Drug | molybdenum disulfide | 2.20e-06 | 43 | 49 | 4 | CID000014823 | |
| Drug | propham | 2.41e-06 | 44 | 49 | 4 | CID000024685 | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 4.23e-06 | 199 | 49 | 6 | 7071_DN | |
| Drug | ridogrel | 4.75e-06 | 52 | 49 | 4 | CID005362391 | |
| Drug | NSC56408 | 9.63e-06 | 62 | 49 | 4 | CID000005604 | |
| Drug | kt S | 1.24e-05 | 66 | 49 | 4 | CID006399216 | |
| Drug | ganoine | 1.36e-05 | 3 | 49 | 2 | CID000131592 | |
| Drug | azelastine | 1.95e-05 | 74 | 49 | 4 | CID000002267 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.43e-05 | 182 | 49 | 5 | 3887_DN | |
| Drug | BW755C | 4.80e-05 | 93 | 49 | 4 | CID000047795 | |
| Drug | bipy | 5.66e-05 | 97 | 49 | 4 | CID000001474 | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 3194_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 3454_DN | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; PC3; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 6884_DN | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 3483_DN | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 4958_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 1299_DN | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5348_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 6426_DN | |
| Drug | carbonyl sulfide | 1.14e-04 | 116 | 49 | 4 | CID000010039 | |
| Drug | AC1L1D09 | 1.17e-04 | 44 | 49 | 3 | CID000002139 | |
| Drug | TXB2 (thromboxane B2 | 1.21e-04 | 118 | 49 | 4 | CID000005461 | |
| Drug | turimycin | 1.62e-04 | 9 | 49 | 2 | CID005282189 | |
| Disease | Male sterility due to Y-chromosome deletions | 4.29e-10 | 8 | 48 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 4.29e-10 | 8 | 48 | 4 | C1507149 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.23e-06 | 16 | 48 | 3 | cv:C1839071 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.23e-06 | 16 | 48 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.23e-06 | 16 | 48 | 3 | 415000 | |
| Disease | amelogenesis imperfecta type 1E (implicated_via_orthology) | 2.59e-06 | 2 | 48 | 2 | DOID:0110058 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 7.52e-06 | 447 | 48 | 7 | C3714756 | |
| Disease | autosomal dominant hypocalcemia (biomarker_via_orthology) | 1.55e-05 | 4 | 48 | 2 | DOID:0090109 (biomarker_via_orthology) | |
| Disease | breast carcinoma (is_implicated_in) | 7.59e-04 | 25 | 48 | 2 | DOID:3459 (is_implicated_in) | |
| Disease | neuroimaging measurement, brain volume measurement | 1.20e-03 | 286 | 48 | 4 | EFO_0004346, EFO_0006930 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.52e-03 | 139 | 48 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | chronic kidney disease, diabetic nephropathy | 1.58e-03 | 36 | 48 | 2 | EFO_0000401, EFO_0003884 | |
| Disease | prostate cancer (is_marker_for) | 2.11e-03 | 156 | 48 | 3 | DOID:10283 (is_marker_for) | |
| Disease | schizophrenia (is_marker_for) | 2.35e-03 | 44 | 48 | 2 | DOID:5419 (is_marker_for) | |
| Disease | Alzheimer's disease biomarker measurement | 2.79e-03 | 48 | 48 | 2 | EFO_0006514 | |
| Disease | serum non-albumin protein measurement | 2.81e-03 | 361 | 48 | 4 | EFO_0004568 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.90e-03 | 49 | 48 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Huntington's disease (is_marker_for) | 3.39e-03 | 53 | 48 | 2 | DOID:12858 (is_marker_for) | |
| Disease | testosterone measurement | 4.32e-03 | 1275 | 48 | 7 | EFO_0004908 | |
| Disease | Arsenic Induced Polyneuropathy | 4.60e-03 | 62 | 48 | 2 | C0751852 | |
| Disease | Arsenic Encephalopathy | 4.60e-03 | 62 | 48 | 2 | C0751851 | |
| Disease | Arsenic Poisoning | 4.60e-03 | 62 | 48 | 2 | C0311375 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPPVQPPQHPRAEQ | 1121 | Q9UKV3 | |
| PVQPQPHQPMQPQPP | 131 | Q99217 | |
| PPALVAQQPPPPPQQ | 346 | Q5SZQ8 | |
| SLQPQPPPHPRPAVV | 166 | P19419 | |
| PVQPQPHQPMQPQPP | 146 | Q99218 | |
| PVHPPRPERQQQPPG | 466 | A8MYA2 | |
| QPPPQPPAVTPEPVA | 201 | P46379 | |
| PQPNPPPVQATPHPF | 211 | O60885 | |
| PAPAPQPVQSHPPII | 261 | O60885 | |
| PPLPPPPHPSVQQQL | 956 | O60885 | |
| QPQPPPQQQHQPPPR | 981 | O60885 | |
| PPPYQEPRPRGNPPH | 481 | Q08345 | |
| QPQVPAPPQPRPPGH | 51 | Q5VV41 | |
| PVHPPPPGPREPAQQ | 1091 | O15085 | |
| PRPLVVNPPPPPQFQ | 126 | Q13117 | |
| PRPLVVNPPPPPQFQ | 126 | Q9NR90 | |
| PPPPVRQEPSPKPNN | 51 | Q8N684 | |
| FPAPRIGPQPQPHPQ | 946 | Q9H3S7 | |
| PPHLPSQPPQQPPQQ | 191 | Q5VYV0 | |
| PEQPRHPPQPQPQPQ | 31 | A0A0U1RRL7 | |
| HPPQPQPQPQPQPQP | 36 | A0A0U1RRL7 | |
| PPPPAPGPHLVQQPN | 1631 | Q8IZD2 | |
| QQPQQKTPLPAPPPP | 401 | Q99583 | |
| PVPPPDLQPSPPRQQ | 1061 | Q9UPP2 | |
| QPPQPLRDPHPAPPR | 406 | O15265 | |
| PPVPAPQPQQSPAPR | 36 | Q9NWA0 | |
| PRPLVVNPPPPPQFQ | 126 | Q9NQZ3 | |
| PRPLVVNPPPPPQFQ | 291 | Q9NQZ3 | |
| PRPLVVNPPPPPQFQ | 456 | Q9NQZ3 | |
| QRPPPQPPQAQAPQP | 21 | Q15329 | |
| PPPPPPLPQERNNVG | 61 | Q86XK2 | |
| HLLQPIGPQQPPPQP | 736 | O15063 | |
| RQPPPPAPQHPQPGS | 31 | Q9NVF7 | |
| PVHPAPLPEAPQPQR | 1136 | Q6VMQ6 | |
| PRPLVVNPPPPPQFQ | 126 | Q86SG3 | |
| PRPLVVNPPPPPQFQ | 291 | Q86SG3 | |
| QPPLAAPPQKPQPHP | 521 | Q92777 | |
| PLQHQQPPPPAGPRP | 166 | Q4G112 | |
| VAHPPAVPPRPQPSQ | 581 | Q96D71 | |
| QNNLAHPPAPPVPPR | 1281 | Q07890 | |
| PPPLPAPADQTQPPH | 71 | Q6T4R5 | |
| QTPRPQPGPIPPHTQ | 2016 | Q6ZNJ1 | |
| QPPAPIQPQSVPPPI | 1066 | Q9Y520 | |
| IPTHGIQPQPQPPPQ | 211 | Q96ST3 | |
| IQPQPQPPPQHPSQP | 216 | Q96ST3 | |
| QPPPGPLPQAPQAVH | 166 | Q3SXP7 | |
| PQPLGPQPVHRPNPL | 2916 | Q6ZRS2 | |
| PKPPIPPPPPHQQQQ | 56 | P23246 | |
| PPPPPHQQQQQPPPQ | 61 | P23246 | |
| PQAPPPQPTQPLQPK | 2726 | O15417 | |
| SPLEQHPQPPLPPPV | 1296 | Q92545 | |
| HPQPPLPPPVPQPQE | 1301 | Q92545 | |
| LPPPVPQPQEPQPER | 1306 | Q92545 | |
| RHPPPPPFQNQQRPP | 81 | Q16378 | |
| PHQVPPQPQTQPPPT | 571 | Q96JM2 | |
| PPPPQLQPQLPRHYQ | 1691 | O60346 | |
| PQPVVPLQPVPPHLP | 746 | Q9Y3S1 | |
| ESPPHPPPQPQVCPT | 136 | Q6ZS46 | |
| QPQPPPQPEPRSVPQ | 231 | Q9P2Y4 | |
| APPPLPPPGQQVIHV | 6 | Q9GZV5 | |
| PHQPPPPQQAPVVAA | 216 | Q96RE7 | |
| QQPPQHRVAPARPPP | 276 | Q96SB3 |